Low molecular weight heparins could be important in cancer
- PMID: 10496841
- PMCID: PMC1116675
Low molecular weight heparins could be important in cancer
Comment on
-
Antithrombotic therapy in cancer.BMJ. 1999 Jun 12;318(7198):1571-2. doi: 10.1136/bmj.318.7198.1571. BMJ. 1999. PMID: 10364099 Free PMC article. No abstract available.
References
-
- Green D, Hull RD, Brant R, Pineo GF. Lower mortality in cancer patients treated with low-molecular weight heparin versus standard heparin. Lancet. 1992;339:1476. - PubMed
-
- Siragusa S, Cosmi B, Piovella F, Hirsh J, Ginsberg JS. Low-molecular weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. Am J Med. 1996;100:269–277. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical